Interactions of platelet activating factor, thromboxane A2 and leukotrienes in guinea-pig heart.
Piper
P J
PJ
Department of Pharmacology, Hunterian Institute, Royal College of Surgeons, of England, London.
Yaacob
H B
HB
D000707:Anaphylaxis / Q000503:physiopathology; D000818:Animals; D001381:Azepines / Q000494:pharmacology; D016861:Cyclooxygenase Inhibitors; D006168:Guinea Pigs; D006321:Heart / Q000503:physiopathology*; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D015289:Leukotrienes / Q000502:physiology*; D016859:Lipoxygenase Inhibitors; D009285:Naphthoquinones / Q000494:pharmacology; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors / Q000502:physiology*; D013928:Thromboxane A2 / Q000502:physiology*; D014227:Triazines / Q000494:pharmacology; D014230:Triazoles; D062367:ortho-Aminobenzoates / Q000494:pharmacology
D001381:Azepines; D016861:Cyclooxygenase Inhibitors; D015289:Leukotrienes; D016859:Lipoxygenase Inhibitors; D009285:Naphthoquinones; D010972:Platelet Activating Factor; D014227:Triazines; D014230:Triazoles; D062367:ortho-Aminobenzoates; C052518:WEB 2086; C055523:methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate; D013928:Thromboxane A2; D007213:Indomethacin